Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005336697 | SCV006001100 | uncertain significance | Cardiovascular phenotype | 2025-03-03 | criteria provided, single submitter | clinical testing | The p.K118N variant (also known as c.354A>T), located in coding exon 3 of the FKBP14 gene, results from an A to T substitution at nucleotide position 354. The lysine at codon 118 is replaced by asparagine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |